Jay Overholser - Search Results

Year	Number of Results
2002	1
2013	1
2014	2
2015	1
2019	1
2020	1
2022	3
2023	1
2024	0

1

Mitochondrial VDAC1: A Potential Therapeutic Target of Inflammation-Related Diseases and Clinical Opportunities.

Hu H, Guo L, Overholser J, Wang X. Hu H, et al. Among authors: overholser j. Cells. 2022 Oct 10;11(19):3174. doi: 10.3390/cells11193174. Cells. 2022. PMID: 36231136 Free PMC article. Review.

2

Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction.

Overholser J, Guo L, Kaumaya PTP. Overholser J, et al. J Vis Exp. 2023 Jul 7;(197). doi: 10.3791/65467. J Vis Exp. 2023. PMID: 37486131

3

A newly discovered PD-L1 B-cell epitope peptide vaccine (PDL1-Vaxx) exhibits potent immune responses and effective anti-tumor immunity in multiple syngeneic mice models and (synergizes) in combination with a dual HER-2 B-cell vaccine (B-Vaxx).

Guo L, Overholser J, Darby H, Ede NJ, Kaumaya PTP. Guo L, et al. Among authors: overholser j. Oncoimmunology. 2022 Oct 5;11(1):2127691. doi: 10.1080/2162402X.2022.2127691. eCollection 2022. Oncoimmunology. 2022. PMID: 36211807 Free PMC article.

4

Preclinical Studies of a Novel Human PD-1 B-Cell Peptide Cancer Vaccine PD1-Vaxx From BALB/c Mice to Beagle Dogs and to Non-Human Primates (Cynomolgus Monkeys).

Guo L, Overholser J, Good AJ, Ede NJ, Kaumaya PTP. Guo L, et al. Among authors: overholser j. Front Oncol. 2022 May 13;12:826566. doi: 10.3389/fonc.2022.826566. eCollection 2022. Front Oncol. 2022. PMID: 35646678 Free PMC article.

5

Immunogenicity and antitumor efficacy of a novel human PD-1 B-cell vaccine (PD1-Vaxx) and combination immunotherapy with dual trastuzumab/pertuzumab-like HER-2 B-cell epitope vaccines (B-Vaxx) in a syngeneic mouse model.

Kaumaya PTP, Guo L, Overholser J, Penichet ML, Bekaii-Saab T. Kaumaya PTP, et al. Among authors: overholser j. Oncoimmunology. 2020 Oct 1;9(1):1818437. doi: 10.1080/2162402X.2020.1818437. Oncoimmunology. 2020. PMID: 33117602 Free PMC article.

6

Phase I Immunotherapy Trial with Two Chimeric HER-2 B-Cell Peptide Vaccines Emulsified in Montanide ISA 720VG and Nor-MDP Adjuvant in Patients with Advanced Solid Tumors.

Bekaii-Saab T, Wesolowski R, Ahn DH, Wu C, Mortazavi A, Lustberg M, Ramaswamy B, Fowler J, Wei L, Overholser J, Kaumaya PTP. Bekaii-Saab T, et al. Among authors: overholser j. Clin Cancer Res. 2019 Jun 15;25(12):3495-3507. doi: 10.1158/1078-0432.CCR-18-3997. Epub 2019 Feb 25. Clin Cancer Res. 2019. PMID: 30804020 Free PMC article. Clinical Trial.

7

Peptide vaccines and peptidomimetics of EGFR (HER-1) ligand binding domain inhibit cancer cell growth in vitro and in vivo.

Foy KC, Wygle RM, Miller MJ, Overholser JP, Bekaii-Saab T, Kaumaya PT. Foy KC, et al. Among authors: overholser jp. J Immunol. 2013 Jul 1;191(1):217-27. doi: 10.4049/jimmunol.1300231. Epub 2013 May 22. J Immunol. 2013. PMID: 23698748 Free PMC article.

8

IGF-1R peptide vaccines/mimics inhibit the growth of BxPC3 and JIMT-1 cancer cells and exhibit synergistic antitumor effects with HER-1 and HER-2 peptides.

Foy KC, Miller MJ, Overholser J, Donnelly SM, Nahta R, Kaumaya PT. Foy KC, et al. Among authors: overholser j. Oncoimmunology. 2014 Dec 21;3(11):e956005. doi: 10.4161/21624011.2014.956005. eCollection 2014 Nov. Oncoimmunology. 2014. PMID: 25941587 Free PMC article.

9

HER-3 peptide vaccines/mimics: Combined therapy with IGF-1R, HER-2, and HER-1 peptides induces synergistic antitumor effects against breast and pancreatic cancer cells.

Miller MJ, Foy KC, Overholser JP, Nahta R, Kaumaya PT. Miller MJ, et al. Among authors: overholser jp. Oncoimmunology. 2014 Dec 21;3(11):e956012. doi: 10.4161/21624011.2014.956012. eCollection 2014 Nov. Oncoimmunology. 2014. PMID: 25941588 Free PMC article.

10

Anti-Tumor Effects of Peptide Therapeutic and Peptide Vaccine Antibody Co-targeting HER-1 and HER-2 in Esophageal Cancer (EC) and HER-1 and IGF-1R in Triple-Negative Breast Cancer (TNBC).

Overholser J, Ambegaokar KH, Eze SM, Sanabria-Figueroa E, Nahta R, Bekaii-Saab T, Kaumaya PT. Overholser J, et al. Vaccines (Basel). 2015 Jul 6;3(3):519-43. doi: 10.3390/vaccines3030519. Vaccines (Basel). 2015. PMID: 26350593 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

11 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year